Detalhe da pesquisa
1.
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.
J Antimicrob Chemother
; 72(3): 829-836, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999018
2.
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
J Virol
; 89(18): 9189-99, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109727
3.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
J Antimicrob Chemother
; 70(6): 1833-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724985
4.
Human CD3γ, but not CD3δ, haploinsufficiency differentially impairs γδ versus αß surface TCR expression.
BMC Immunol
; 14: 3, 2013 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23336327
5.
Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.
AIDS Res Hum Retroviruses
; 39(5): 211-221, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416229
6.
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.
J Virol
; 85(21): 11468-78, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21865377
7.
The role of the different CD3γ domains in TCR expression and signaling.
Front Immunol
; 13: 978658, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119034
8.
Effects on immune system and viral reservoir of a short-cycle antiretroviral therapy in virologically suppressed HIV-positive patients.
AIDS
; 33(6): 965-972, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946150
9.
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.
Vaccines (Basel)
; 7(4)2019 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703287
10.
A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity.
AIDS
; 32(12): 1633-1641, 2018 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746294
11.
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.
AIDS
; 32(17): 2533-2545, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289805
12.
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
PLoS One
; 13(4): e0195915, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634751
13.
Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression.
Front Immunol
; 8: 836, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28785262
14.
Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
AIDS
; 31(13): 1895-1897, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28590333
15.
Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling.
J Immunol Methods
; 442: 12-19, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039100
16.
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
AIDS
; 31(3): 321-332, 2017 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27677160
17.
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
PLoS One
; 12(10): e0186602, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29065142
18.
MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
PLoS One
; 11(5): e0155245, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27171002
19.
Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.
Expert Rev Anti Infect Ther
; 13(6): 751-67, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25860288
20.
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
J Acquir Immune Defic Syndr
; 69(2): 206-15, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25831464